GS1
New drug discovery pathway based on proteomics and structural information
GS1-1.
Structural biology of transcriptional regulation mechanisms by the Ets transcription factor family
GS1-2.
Development of artificial enzymes based on the myoglobin scaffold
GS1-3.
Structural basis of the collagen-binding mode of discoidin domain receptor 2
GS1-4.
Establishment of antibody proteomics for identification of disease-related proteins and high-throughput isolation of monoclonal antibodies
GS1-5.
Drug discovery for amyotrophic lateral sclerosis based on proteome informations: intracellular copper distribution is potential drug target
GS1-6.
Development of a high-throughput system for creation of functional mutant proteins useful for pharmaceutical proteomics